Rejeunesse Deep 1.1ml syringe
Safe products with ISO certifications
Fast shipping worldwide with DHL, EMS, Etc.
Return policy in the event of errors on our part
Rejeunesse Deep filler is a hyaluronic acid filler that is truly appreciated not only by patients but also by aesthetic dermatologists. It adds a lot of volume to areas of the face with deep wrinkles and can also be used for the contours of the patient's face. The concentration of HA in this filler is 24 mg / ml and is used to be injected into the medium or deep dermis. Rejeunesse Deep succeeds where many other dermal fillers fail in the enterprise, because it combats both medium and more severe facial wrinkles, eliminating most moderate or deep wrinkles on the glabella and in many parts of the face. This is possible thanks to the high viscoelasticity properties of this product and the innovative technology of cross-linked hyaluronic acid that has been used for the production of this filler, it offers a rapid and long-lasting treatment by having molecules of cross-linked hyaluronic acid that can give any face with signs of aging, to appear younger and with a fresher skin. Deep is one of the most effective lip fillers there are. This high quality HA-based injectable gel is one of the best options for improving lip volume and the shape of lip lines. Rejeunesse Deep filler has an effect longer than the average 8 to 12 months after a single session. Contains 1.1ml of lidocaine to minimize pain and discomfort and is equally effective in treating medium to deep wrinkles or creases. The product has excellent viscoelasticity, more suitable for fillers injected into areas such as the lips, and is soft enough to also be very effective in the treatment of moderate wrinkles, fill low to medium skin depressions or hide problems such as medium glabella. size or puppet lines. As a lip enhancement solution, Rejeunesse Deep can be readily used by all patients, with the exception of pregnant, breastfeeding or allergic women over the age of 18. As an anti-aging product, older patients at the age of 35 they will derive greater benefits.